1. Home
  2. WST vs AVY Comparison

WST vs AVY Comparison

Compare WST & AVY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WST
  • AVY
  • Stock Information
  • Founded
  • WST 1923
  • AVY 1935
  • Country
  • WST United States
  • AVY United States
  • Employees
  • WST N/A
  • AVY N/A
  • Industry
  • WST Medical/Dental Instruments
  • AVY Containers/Packaging
  • Sector
  • WST Health Care
  • AVY Consumer Discretionary
  • Exchange
  • WST Nasdaq
  • AVY Nasdaq
  • Market Cap
  • WST 15.6B
  • AVY 14.4B
  • IPO Year
  • WST N/A
  • AVY N/A
  • Fundamental
  • Price
  • WST $263.31
  • AVY $177.82
  • Analyst Decision
  • WST Buy
  • AVY Buy
  • Analyst Count
  • WST 7
  • AVY 10
  • Target Price
  • WST $332.50
  • AVY $197.00
  • AVG Volume (30 Days)
  • WST 852.1K
  • AVY 730.4K
  • Earning Date
  • WST 07-24-2025
  • AVY 07-22-2025
  • Dividend Yield
  • WST 0.33%
  • AVY 2.11%
  • EPS Growth
  • WST N/A
  • AVY 14.63
  • EPS
  • WST 6.68
  • AVY 8.92
  • Revenue
  • WST $2,960,200,000.00
  • AVY $8,737,900,000.00
  • Revenue This Year
  • WST $3.38
  • AVY $2.36
  • Revenue Next Year
  • WST $5.82
  • AVY $4.11
  • P/E Ratio
  • WST $39.42
  • AVY $19.93
  • Revenue Growth
  • WST 2.90
  • AVY 1.66
  • 52 Week Low
  • WST $187.43
  • AVY $157.00
  • 52 Week High
  • WST $352.33
  • AVY $224.38
  • Technical
  • Relative Strength Index (RSI)
  • WST 67.71
  • AVY 46.71
  • Support Level
  • WST $206.80
  • AVY $168.78
  • Resistance Level
  • WST $291.00
  • AVY $184.44
  • Average True Range (ATR)
  • WST 8.40
  • AVY 3.89
  • MACD
  • WST 4.53
  • AVY -0.37
  • Stochastic Oscillator
  • WST 67.11
  • AVY 50.79

About WST West Pharmaceutical Services Inc.

West Pharmaceutical Services is based in Pennsylvania, US, and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs, which include large molecule biologics, peptides such as GLP-1 receptor agonists, and small molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.

About AVY Avery Dennison Corporation

Avery Dennison manufactures pressure-sensitive materials, merchandise tags, and labels. The company also runs a specialty converting business that produces radio-frequency identification, or RFID, inlays and labels. Avery Dennison draws a significant amount of revenue from outside the United States, with international operations accounting for the majority of total sales.

Share on Social Networks: